Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Kaunas invites to experience magic of contemporary circus

“ Cirkuliacija ” is inviting everyone for a festive experience that is accessible, interesting and...

The European Night of Museums in Kaunas: what to wait

Since 2011, the International Council of Museums has been sponsoring The European Night of Museums...

Lithuanian pavilion at Venice Biennale gets top reward

Lithuania's pavilion at the 58th Venice Biennale features an artificial beach where "vacationers"...

Lithuanian pavilion opens at Venice Biennale

Lithuania's pavilion at the 58th Venice Biennale features an artificial beach where "vacationers"...

Exhibition of world-recognised Litvak artist will be opened in his hometown

In 1932, Arbit Blatas opened the first private gallery in the Baltics in Kaunas . On May 11, the...